In addition, in SGC-7901 mouse xenografts, 1.5 EGCG mg/day intraperitoneally injected reduced VEGF, tumor microvessel density, endothelial cell proliferation, migration, and tube formation, substantially blocking tumor growth [132]. The gene discussed is VEGFA; the disease is neoplasm.